Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?

Area of Science:

• Endocrinology
• Oncology
• Immunology

Background:

• Hashimoto's thyroiditis (HT) is the leading cause of hypothyroidism, affecting women seven times more than men.
• Papillary thyroid cancer (PTC) is the most common thyroid malignancy, also more prevalent in women (2.5x).
• This study investigates the potential correlation between HT and PTC in female patients.

Purpose of the Study:

• To determine if a correlation exists between Hashimoto's thyroiditis and papillary thyroid cancer in women.
• To assess the impact of HT on the incidence of PTC in a cohort of thyroid surgery patients.

Main Methods:

• Retrospective analysis of 1198 thyroid surgery patients from May 1994 to January 2007.
• Statistical analysis of 217 patients diagnosed with HT (196 women, 21 men) using SPSS.
• Comparison of PTC rates in patients with and without HT, stratified by sex and presence of goiter.

Main Results:

• PTC was diagnosed in 29% of HT patients versus 23% of non-HT patients (P=0.051).
• Women with HT had a higher incidence of PTC (29%) compared to women without HT (22%, P=0.03).
• Female HT patients with goiters showed a significantly lower PTC rate (9%) than those without goiters (36%, P<0.001).

Conclusions:

• Hashimoto's thyroiditis is associated with an elevated risk of developing papillary thyroid cancer.
• Female patients with HT undergoing thyroidectomy exhibit a 30% increased likelihood of concurrent PTC.
• Increased surveillance for PTC is recommended for patients diagnosed with HT, particularly women.